Trial Profile
The Comparison Between the Therapeutic Effect of Intravitreal Bevacizumab and Ziv-aflibercept in Diabetic Macular Edema
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 26 Feb 2020
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary) ; Bevacizumab
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 11 Jan 2016 New trial record